Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation

T M Davis

doi:10.1345/aph.18239

Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation

T M Davis

Internal Medicine

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	1104-6
Number of pages	3
Journal	The Annals of Pharmacotherapy
Volume	32
Issue number	10
DOIs	https://doi.org/10.1345/aph.18239
Publication status	Published - Oct 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1345/aph.18239

Cite this

@article{bc35ad0de76945748cd3594043d40c6b,

title = "Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation",

keywords = "Animals, Anti-Bacterial Agents/adverse effects, Antimalarials/adverse effects, Atovaquone, Azithromycin/adverse effects, Chloroquine/adverse effects, Drug Therapy, Combination, Humans, Malaria/prevention & control, Mefloquine/adverse effects, Naphthoquinones/adverse effects, Plasmodium falciparum/drug effects, Plasmodium vivax/drug effects, Primaquine/adverse effects, Proguanil/adverse effects, Pyrimethamine/adverse effects, Risk Assessment",

author = "Davis, {T M}",

year = "1998",

month = oct,

doi = "10.1345/aph.18239",

language = "English",

volume = "32",

pages = "1104--6",

journal = "The Annals of Pharmacotherapy",

issn = "1060-0280",

publisher = "SAGE Publications Ltd",

number = "10",

}

TY - JOUR

T1 - Adverse effects of antimalarial prophylactic drugs

T2 - an important consideration in the risk-benefit equation

AU - Davis, T M

PY - 1998/10

Y1 - 1998/10

KW - Animals

KW - Anti-Bacterial Agents/adverse effects

KW - Antimalarials/adverse effects

KW - Atovaquone

KW - Azithromycin/adverse effects

KW - Chloroquine/adverse effects

KW - Drug Therapy, Combination

KW - Humans

KW - Malaria/prevention & control

KW - Mefloquine/adverse effects

KW - Naphthoquinones/adverse effects

KW - Plasmodium falciparum/drug effects

KW - Plasmodium vivax/drug effects

KW - Primaquine/adverse effects

KW - Proguanil/adverse effects

KW - Pyrimethamine/adverse effects

KW - Risk Assessment

U2 - 10.1345/aph.18239

DO - 10.1345/aph.18239

M3 - Article

C2 - 9793605

SN - 1060-0280

VL - 32

SP - 1104

EP - 1106

JO - The Annals of Pharmacotherapy

JF - The Annals of Pharmacotherapy

IS - 10

ER -